Chronic cough, a prevalent and often vexing condition, poses a significant diagnostic and therapeutic challenge to healthcare professionals. Understanding its complexities is crucial for effective management.
Chronic cough can be attributed to a variety of underlying conditions like gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS). Pathophysiologically, it's a defensive reflex mechanism, often amplified by inflammation or irritants.
Diagnostics should be comprehensive and systematic. It includes a thorough patient history, physical examination, and relevant investigations like chest X-rays, spirometry, and, if required, bronchoscopy.
Treatment is primarily based on identifying and managing the underlying cause. Symptomatic relief can be achieved through antitussive agents, inhaled corticosteroids, or neuromodulators.
Chronic cough requires a diligent, patient-centric approach. By understanding its etiology, pathophysiology, and applying a comprehensive diagnostic and therapeutic plan, healthcare professionals can significantly enhance patient outcomes.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation